Digital Health Startups

ResVent develops respiratory and critical care medical devices, including invasive and non-invasive ventilators and diagnostic equipment for hospital critical care and chronic respiratory disease management.

1 investor

Retia Medical develops advanced hemodynamic monitoring devices, including the Argos Cardiac Output Monitor, which uses proprietary algorithms to provide real-time clinical decision support for high-risk patients. The company's products support clinicians in critical care and perioperative settings.

1 investor

Reticular offers an at-home saliva (cheek swab) genetic screening service that tests 750+ reproductive genes in one or both partners, paired with licensed genetic counseling, to provide context on fertility, early embryo development, and pregnancy loss. It serves people planning a pregnancy, those with unexplained infertility or recurrent pregnancy loss, and also offers embryo reports for users with existing embryo sequencing data.

1 investor

Reticular provides genetic screening and embryo analysis for prospective parents, offering risk assessments for pregnancy loss, inherited diseases, and health traits to inform reproductive decisions.

1 investor

RetiDiag provides teleophthalmology services and visual health field operations to detect, evaluate, and monitor eye conditions, connecting clinical teams and professionals to improve access to specialized eye care. It serves health institutions such as primary care centers (CESFAM), hospitals, municipalities, and health organizations, with a focus on communities with limited access to specialized care in Chile.

1 investor

RetinaCheck was a Sino-Dutch research project and TU/e startup that developed computer-aided diagnosis software using geometric methods and deep learning to automatically analyze retinal fundus images for early detection of diabetic retinopathy and other eye diseases. Aimed at large-scale diabetes screening programs in China, the startup was acquired by the He Vision Group in 2020.

1 investor

IRIS is cloud-based, camera-agnostic retinal screening software that lets healthcare providers capture, enhance, and diagnose diabetic retinopathy, with board-certified eye specialists interpreting the images. It serves hospitals, health systems, federally qualified health centers, health plans, labs, pharmacies, and health risk assessment companies to close care gaps and reduce costs.

1 investor

RetMap develops next-generation electroretinography sensors and diagnostic medical devices for screening, diagnosis, and treatment of neurodegenerative eye conditions. The company serves ophthalmologists and clinicians seeking to detect and manage retinal diseases and prevent vision loss.

1 investor

Revealix is a clinical decision support platform for diabetic foot health risk assessment that enables healthcare providers to screen, document, and stratify patient risk in a 3-minute mobile workflow. The platform is designed to help intercept foot wound risk in primary care settings before wounds develop, addressing preventable complications in people with diabetes.

1 investor

Revela Health develops software that performs enhanced AI analysis of routinely captured ultrasound scans to identify subtle signs of endometriosis, returning structured reports to clinicians. The technology aims to shorten the diagnostic pathway for women experiencing pelvic pain by supporting earlier diagnosis and treatment planning.

1 investor

ReverCare provides digital tools and guidance to help older adults and their family caregivers navigate care-related challenges, including access to expert coaches and information on solutions like home care, estate planning, and emergency response systems.

1 investor

Reveri is a self-hypnosis application that delivers clinically validated relief from pain, stress, and sleeplessness without drugs or appointments. Built on decades of clinical research, it offers on-demand hypnosis sessions to consumers seeking help with physical and emotional issues such as anxiety, sleep, and addiction.

1 investor

ReVIDA Recovery operates a network of outpatient recovery centers that treat opioid use disorder using Medication Assisted Treatment (MAT) and a multi-disciplinary behavioral healthcare approach. It serves patients across Middle and Eastern Tennessee and Southwest Virginia, with a focus on the Appalachia region.

1 investor

Reviewwave (branded as Aloha) offers an AI-powered patient engagement platform for healthcare practices, with tools for reviews, online scheduling, two-way texting, web chat, referrals, digital forms, and marketing automation. It integrates with major EHR and practice management systems and serves specialties including chiropractic and optometry.

1 investor

Reviva is an AI practice-management platform for healthcare and aesthetic practices, handling scheduling, charting, payments, patient outreach, memberships, and inventory. It surfaces tasks like rebooking gaps and membership renewals and includes an onboarding agent that builds service menus, chart templates, and intake forms and migrates existing practice data.

1 investor

Reviva Pharmaceuticals is a clinical-stage drug developer with a pipeline of two in-house-discovered new chemical entities, brilaroxazine (RP5063) and RP1208, developed using its chemical genomics platform. Its lead candidate, brilaroxazine, is being developed for schizophrenia and has completed a Phase 3 trial.

1 investor

Rewire AI builds automated image-analysis tools for biomedical researchers, using machine learning to detect, count, and quantify cells, fluorescent probes, and biomarkers in tissue histology. Its technology serves scientists as well as biotech and digital health companies through model development and AI-layer licensing.

1 investor

Rhelixa provides genomic and epigenomic analysis services and consulting to life science researchers, as well as a cloud-based research support platform for medical and biological research. The company also conducts research and development related to anti-aging.

1 investor

Rheumasense develops clinical diagnostic testing technology aimed at transforming the management and care of rheumatoid arthritis. The company is advancing its diagnostic platform toward FDA submission and commercialization.

1 investor

Rhodes Health is the practice of Orli Rhodes, a registered dietitian offering personalised diet and nutrition consultations for conditions such as diabetes, food intolerances, digestive and metabolic disorders, and weight management. It provides online and in-clinic one-on-one support plus nutrition talks and workshops for schools, corporate clients, and events, based in London.

1 investor

RhoDx develops cell-free DNA and RNA enrichment technologies for liquid biopsy cancer diagnostics. The company provides ultra-sensitive mutation detection methods to improve the performance and accessibility of liquid biopsy testing.

1 investor

Rhovica Neuroimaging AG develops a patented navigation system for safe placement of brain catheters in acute cerebral hemorrhage cases, enabling real-time monitoring and bedside treatment in emergency settings. The company serves hospitals and emergency care providers in the medical device and neurosurgery sector.

1 investor

RIFFIT uses artificial intelligence to enable music creation for people of all skill levels, with a focus on supporting individuals with neurological conditions like dyslexia, autism, and aphasia through music therapy applications.

1 investor

Rio Health offers on-demand delivery of medicines, baby items, and pet supplies to consumers, with orders placed via WhatsApp and delivery in as little as 15 minutes. It carries over 10,000 products aimed at people needing urgent household and health essentials.

1 investor